01 1Hetero Drugs
01 1RELUGOLIX (FORM-1)
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2024-10-22
Pay. Date : 2024-09-24
DMF Number : 40410
Submission : 2024-09-27
Status : Active
Type : II
20
Hetero Labs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RELUGOLIX (FORM-1), with a corresponding US DMF Number 40410.
Remarkably, this DMF maintains an Active status since its submission on September 27, 2024, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 22, 2024, and payment made on September 24, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II
